γ-Aminobutyric acid type A receptors and alcoholism: Intoxication, dependence, vulnerability, and treatment

Archives of General Psychiatry

Volumn 63, Issue 9, 2006, Pages 957-968

  Krystal, John H ^a,b,c,h   Staley, Julie ^a,b,c   Mason, Graeme ^a   Petrakis, Ismene L ^a,b   Kaufman, Joan ^a,b,d,e   Harris, R Adron ^f   Gelernter, Joel ^a,b   Lappalainen, Jaakko ^a,b,g  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Yale University School of Medicine   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Child and Adolescent Research and Education Program   (United States)

^f UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^g ASTRAZENECA   (United Kingdom)

^h VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ALFAXALONE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CHLORIDE; GABOXADOL; GANAXOLONE; IOMAZENIL; NEUROSTEROID; TOPIRAMATE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ALCOHOL WITHDRAWAL; ALCOHOLISM; BINDING AFFINITY; COMORBIDITY; DRUG DETOXIFICATION; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; MOLECULAR GENETICS; NEUROIMAGING; NEUROSCIENCE; NEUROTRANSMISSION; REVIEW; RISK FACTOR; SMOKING;

ALCOHOLISM; BENZODIAZEPINES; BRAIN; CEREBRAL CORTEX; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RECEPTORS, GABA-A; RISK FACTORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33748316516     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.63.9.957     Document Type: Review

References (231)

1. Krystal JH, Tabakoff B. Ethanol abuse, dependence, and withdrawal: neurobiology and clinical implications. In: Davis KL, Charney DS, Coyle JT, Nemeroff C, eds. Psychopharmacology: A Fifth Generation of Progress. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:1425-1443.
2. A receptors in the acute and chronic effects of ethanol. Psychopharmacology (Berl). 1998;139:2-19.
3. Boehm SL II, Ponomarev I, Jennings AW, Whiting PJ, Rosahl TW, Garrett EM, Blednov YA, Harris RA. γ-Aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions. Biochem Pharmacol. 2004;68:1581-1602.
4. Grant KA, Lovinger DM. Cellular and behavioral neurobiology of alcohol: receptor-mediated neuronal processes. Clin Neurosci. 1995;3:155-164.
5. Krystal JH, Petrakis IL, Mason G, D'Souza DC. NMDA glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther. 2003;99:79-94.
6. Mehta AK, Ticku MK. An update on GABAA receptors. Brain Res Brain Res Rev. 1999;29:196-217.
7. Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today. 2003;8:445-450.
8. B receptors. Physiol Rev. 2004;84:835-867.
9. C receptor ion channels. Clin Exp Pharmacol Physiol. 2004;31:800-804.
10. Bowen CA, Grant KA. Pharmacological analysis of the heterogeneous discriminative stimulus effects of ethanol in rats using a three-choice ethanol-dizocilpine-water discrimination. Psychopharmacology (Berl). 1998;139:86-94.
11. de Wit H. Diazepam preference in males with and without an alcoholic first-degree relative. Alcohol Clin Exp Res. 1991;15:593-600.
12. Petrakis IL, Ralevski E, Limoncelli D, Balachandra K, Trevisan L, Krystal J. Barbiturate responses in individuals with a family vulnerability to alcoholism [abstract]. Alcohol Clin Exp Res. 2005;29:97A.
13. Green KL, Grant KA. Evidence for overshadowing by components of the heterogeneous discriminative stimulus effects of ethanol. Drug Alcohol Depend. 1998; 52:149-159.
14. A receptor agonists in rhesus monkeys. Psychopharmacology (Berl). 2005;178:400-409.
15. Massey BW, Woolverton WL. Discriminative stimulus effects of combinations of pentobarbital and ethanol in rhesus monkeys. Drug Alcohol Depend. 1994;35:37-43.
16. Okamoto M, Rao SN, Aaronson LM, Walewski JL. Ethanol drug interaction with chlordiazepoxide and pentobarbital. Alcohol Clin Exp Res. 1985;9:516-521.
17. Ho AK, Ho CC. Toxic interactions of ethanol with other central depressants: antagonism by naloxone to narcosis and lethality. Pharmacol Biochem Behav. 1979; 11:111-114.
18. Palva ES, Linnoila M, Mattila MJ. Effect of active metabolites of chlordiazepoxide and diazepam, alone or in combination with alcohol, on psychomotor skills related to driving. Mod Probl Pharmacopsychiatry. 1976;11:79-84.
19. Le AD, Khanna JM, Kalant H. Effects of chronic treatment with ethanol on the development of cross-tolerance to other alcohols and pentobarbital. J Pharmacol Exp Ther. 1992;263:480-485.
20. Khanna JM, Mihic SJ, Weiner J, Shah G, Wu PH, Kalant H. Differential inhibition by NMDA antagonists of rapid tolerance to, and cross-tolerance between, ethanol and chlordiazepoxide. Brain Res. 1992;574:251-256.
21. Mihic SJ, Kalant H, Liu JF, Wu PH. Role of the γ-aminobutyric acid receptor/chloride channel complex in tolerance to ethanol and cross-tolerance to diazepam and pentobarbital. J Pharmacol Exp Ther. 1992;261:108-113.
22. A receptor-operated chloride channels, II: chronic effects of ethanol. J Pharmacol Exp Ther. 1990;253:713-719.
23. Emmett-Oglesby MW. Tolerance to the discriminative stimulus effects of ethanol. Behav Pharmacol. 1990;1:497-503.
24. Mayo-Smith MF; American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA. 1997;278:144-151.
25. Gatto GJ, Grant KA. Attenuation of the discriminative stimulus effects of ethanol by the benzodiazepine partial inverse agonist Ro 15-4513. Behav Pharmacol. 1997;8:139-146.
26. Kostowski W, Bienkowski P. Discriminative stimulus effects of ethanol: neuropharmacological characterization. Alcohol. 1999;17:63-80.
27. A α5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol. Alcohol Clin Exp Res. 2005;29:1390-1401.
28. Martens F, Koppel C, Ibe K, Wagemann A, Tenczer J. Clinical experience with the benzodiazepine antagonist flumazenil in suspected benzodiazepine or ethanol poisoning. J Toxicol Clin Toxicol. 1990;28:341-356.
29. Lheureux P, Fontaine J, Askenasi R. Effect of flumazenil in a model of acute alcohol intoxication in rats. Hum Exp Toxicol. 1993;12:177-180.
30. Fluckiger A, Hartmann D, Leishman B, Ziegler WH. Lack of effect of the benzodiazepine antagonist flumazenil (Ro 15-1788) on the performance of healthy subjects during experimentally induced ethanol intoxication. Eur J Clin Pharmacol. 1988;34:273-276.
31. June HL, Lewis MJ. Interactions of Ro15-4513, Ro15-1788 (flumazenil) and ethanol on measures of exploration and locomotion in rats. Psychopharmacology (Berl). 1994;116:309-316.
32. Suzdak PD, Schwartz RD, Skolnick P, Paul SM. Ethanol stimulates γ-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci U S A. 1986;83:4071-4075.
33. A-gated chloride channels. J Pharmacol Exp Ther. 1988;246:558-564.
34. Nestoros JN. Ethanol specifically potentiates GABA neurotransmission in feline cerebral cortex. Science. 1980;209:708-710.
35. Allan AM, Harris RA. Acute and chronic ethanol treatments alter GABA receptor-operated chloride channels. Pharmacol Biochem Behav. 1987;27:665-670.
36. Roberto M, Madamba SG, Moore SD, Tallent MK, Siggins GR. Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc Natl Acad Sci U S A. 2003;100:2053-2058.
37. Reynolds JN, Prasad A, MacDonald JF. Ethanol modulation of GABA receptor-activated Cl-currents in neurons of the chick, rat and mouse central nervous system. Eur J Pharmacol. 1992;224:173-181.
38. A and glycine receptors. Nature. 1997;389:385-389.
39. White G, Lovinger DM, Weight FF. Ethanol inhibits NMDA-activated current but does not alter GABA-activated current in an isolated adult mammalian neuron. Brain Res. 1990;507:332-336.
40. Criswell HE, Simson PE, Duncan GE, McCown TJ, Herbert JS, Morrow AL, Breese GR. Molecular basis for regionally specific action of ethanol on γ-aminobutyric acid A receptors: generalization to other ligand-gated ion channels. J Pharmacol Exp Ther. 1993;267:522-537.
41. A-activated currents in adult medial septum/diagonal band neurons. Brain Res. 1994;635:283-292.
42. Givens BS, Breese GR. Site-specific enhancement of γ-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area. J Pharmacol Exp Ther. 1990;254:528-538.
43. Mihic SJ, Wu PH, Kalant H. Potentiation of γ-aminobutyric acid-mediated chloride flux by pentobarbital and diazepam but not ethanol. J Neurochem. 1992;58:745-751.
44. Koski A, Ojanpera I, Vuori E. Alcohol and benzodiazepines in fatal poisonings. Alcohol Clin Exp Res. 2002;26:956-959.
45. A receptors are the molecular substrates mediating precipitation of narcosis but not of sedation by the combined use of diazepam and alcohol in vivo. Eur J Neurosci. 2003;18:2599-2604.
46. Morrow AL, VanDoren MJ, Penland SN, Matthews DB. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Brain Res Rev. 2001;37:98-109.
47. Criswell HE, Breese GR. A conceptualization of integrated actions of ethanol contributing to its GABAmimetic profile: a commentary. Neuropsychopharmacology. 2005;30:1407-1425.
48. Siggins GR, Roberto M, Nie Z. The tipsy terminal: presynaptic effects of ethanol. Pharmacol Ther. 2005;107:80-98.
49. A receptor activity in rat hippocampus. J Neurosci. 2004;24:6521-6530.
50. Hirani K, Sharma AN, Jain NS, Ugale RR, Chopde CT. Evaluation of GABAergic neuroactive steroid 3α-hydroxy-5α-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology (Berl). 2005;180:267-278.
51. Mohler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002;300:2-8.
52. A receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci. 1998;18:1693-1703.
53. A receptors suggest differential targeting of receptor subtypes. J Neurosci. 1999;19:2960-2973.
54. 3δ γ-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci U S A. 2003;100:15218-15223.
55. A receptors. Nat Rev Neurosci. 2005;6:215-219.
56. A receptors. Proc Natl Acad Sci U S A. 2003;100:14439-14444.
57. A receptors containing the δ subunit. J Neurosci. 2002;22:1541-1549.
58. A receptors and their activation by GABA spillover in the mouse dentate gyrus. J Neurosci. 2003;23:10650-10661.
59. A conductances in hippocampal neurons. J Neurosci. 2002;22:RC223. http://www.jneurosci.org/cgi/content/full/22/10/RC223. Accessed July 5, 2006.
60. Borghese CM, Stórustovu S, Ebert B, Herd MB, Belelli D, Lambert JJ, Marshall G, Wafford KA, Harris RA. The δ subunit of γ-aminobutyric acid type A receptors does not confer sensitivity to low concentrations of ethanol. J Pharmacol Exp Ther. 2006;316:1360-1368.
61. A receptors are a target for alcohol. Nat Neurosci. 2002;5:721-722.
62. Harris RA, Allan AM, Daniell LC, Nixon C. Antagonism of ethanol and pentobarbital actions by benzodiazepine inverse agonists: neurochemical studies. J Pharmacol Exp Ther. 1988;247:1012-1017.
63. Middaugh LD, Bao K, Becker HC, Daniel SS. Effects of Ro 15-4513 on ethanol discrimination in C57BL/6 mice. Pharmacol Biochem Behav. 1991;38:763-767.
64. Suzdak PD, Glowa JR, Crawley JN, Schwartz RD, Skolnick P, Paul SM. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science. 1986; 234:1243-1247.
65. Syapin PJ, Jones BL, Kobayashi LS, Finn DA, Alkana RL. Interactions between benzodiazepine antagonists, inverse agonists, and acute behavioral effects of ethanol in mice. Brain Res Bull. 1990;24:705-709.
66. Wallner M, Hanchar HJ, Olsen RW. Low-dose alcohol actions on Q4B3δ GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513. Proc Natl Acad Sci U S A. 2006;102:8540-8545.
67. A receptors. Proc Natl Acad Sci U S A. 2006;103:8546-8551.
68. A receptors in hippocampal neurons. J Neurosci. 2004;24:8379-8382.
69. 2 subunit-containing receptors in cerebellar granule cells. J Biol Chem. 2001;276:10532-10538.
70. A-receptor δ subunit knockout mice have multiple defects in behavioral responses to ethanol. Alcohol Clin Exp Res. 2001;25:1708-1718.
71. Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi ZP, Lagenaur C, Tretter V, Sieghart W, Anagnostaras SG, Sage JR, Fanselow MS, Guidotti A, Spigelman I, Li Z, DeLorey TM, Olsen RW, Homanics GE. Attenuated sensitivity to neuroactive steroids in γ-aminobutyrate type A receptor δ subunit knockout mice. Proc Natl Acad Sci U S A. 1999;96:12905-12910.
72. Areceptor δ subunit. J Neurophysiol. 2003; 90:903-910.
73. 6 subunit of the γ-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol. 1997;51:588-596.
74. A receptor activity. Nat Neurosci. 2005;8:339-345.
75. Shannon EE, Shelton KL, Vivian JA, Yount I, Morgan AR, Homanics GE, Grant KA. Discriminative stimulus effects of ethanol in mice lacking the γ-aminobutyric acid type A receptor δ subunit. Alcohol Clin Exp Res. 2004;28:906-913.
76. Newton PM, Messing RO. Intracellular signaling pathways that regulate behavioral responses to ethanol. Pharmacol Ther. 2006;109:227-237.
77. A receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr Opin Neurobiol. 2003;13:341-347.
78. A-mediated synaptic current by ethanol in hippocampal CA1 neurons: possible role of protein kinase C. J Pharmacol Exp Ther. 1994;268:1388-1395.
79. Harris RA, McQuilkin SJ, Paylor R, Abeliovich A, Tonegawa S, Wehner JM. Mutant mice lacking the γ isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of γ-aminobutyrate type A receptors. Proc Natl Acad Sci U S A. 1995;92:3658-3662.
80. Bowers BJ, Owen EH, Collins AC, Abeliovich A, Tonegawa S, Wehner JM. Decreased ethanol sensitivity and tolerance development in γ-protein kinase C null mutant mice is dependent on genetic background. Alcohol Clin Exp Res. 1999;23:387-397.
81. Bowers BJ, Wehner JM. Ethanol consumption and behavioral impulsivity are increased in protein kinase Cγ null mutant mice. J Neurosci. 2001;21:1-5.
82. Olive MF, Mehmert KK, Messing RO, Hodge CW. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCε-deficient mice. Eur J Neurosci. 2000;12:4131-4140.
83. A receptor modulators and alcohol in mice lacking PKCε. Nat Neurosci. 1999;2:997-1002.
84. A receptor-mediated responses in protein kinase Cγ (PKCγ) and PKCε mice. J Pharmacol Exp Ther. 2003;305:264-270.
85. Choi DS, Wang D, Dadgar J, Chang WS, Messing RO. Conditional rescue of protein kinase Cε regulates ethanol preference and hypnotic sensitivity in adult mice. J Neurosci. 2002;22:9905-9911.
86. Weiner JL, Valenzuela CF. Pharmacol Ther. 2006. doi:10.1016./j. pharmthera.2005.11.002. Ethanol modulation of GABAergic transmission: the view from the slice [published online ahead of print January 19, 2006].
87. Barbaccia ML, Affricano D, Trabucchi M, Purdy RH, Colombo G, Agabio R, Gessa GL. Ethanol markedly increases "GABAergic" neurosteroids in alcoholpreferring rats. Eur J Pharmacol. 1999;384:R1-R2.
88. VanDoren MJ, Matthews DB, Janis GC, Grobin AC, Devaud LL, Morrow AL. Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci. 2000;20:1982-1989.
89. O'Dell LE, Alomary AA, Vallee M, Koob GF, Fitzgerald RL, Purdy RH. Ethanol-induced increases in neuroactive steroids in the rat brain and plasma are absent in adrenalectomized and gonadectomized rats. Eur J Pharmacol. 2004;484:241-247.
90. Holdstock L, Penland SN, Morrow AL, de Wit H. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3α-hydroxy-5α- pregnan-20-one-like immunoreactivity in healthy men and women. Psychopharmacology (Berl). 2005;186:442-450.
91. Pierucci-Lagha A, Covault J, Feinn R, Nellissery M, Hernandez-Avila C, Oncken C, Morrow AL, Kranzler HR. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride. Neuropsychopharmacology. 2005;30:1193-1203.
92. B receptors. J Neurosci. 2004;24:10679-10686.
93. Carta M, Mameli M, Valenzuela CF. Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability. J Neurosci. 2004;24:3746-3751.
94. Carta M, Ariwodola OJ, Weiner JL, Valenzuela CF. Alcohol potently inhibits the kainate receptor-dependent excitatory drive of hippocampal interneurons. Proc Natl Acad Sci U S A. 2003;100:6813-6818.
95. Moghaddam B, Bolinao ML. Biphasic effect of ethanol on extracellular accumulation of glutamate in the hippocampus and the nucleus accumbens. Neurosci Lett. 1994;178:99-102.
96. A synaptic activity in hippocampal CA1 neurons. J Pharmacol Exp Ther. 2005;312:1082-1089.
97. A receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal. J Neurosci. 2003;23:11711-11724.
98. A receptors. Mol Pharmacol. 2003;63:53-64.
99. A receptor expression: potential mechanisms. Neurochem Int. 2000;37:453-461.
100. A receptor-mediated 36 Cl(-) uptake in mesocorticolimbic regions of rat brain. Alcohol Clin Exp Res. 2001;25:1270-1275.
101. A receptor α subunits reveal that chronic alcohol treatment down-regulates α-subunit expression in rat brain regions. J Neurochem. 1993;61:1620-1625.
102. A receptor function and gene expression. Alcohol Alcohol Suppl. 1993;2:331-335.
103. A receptor α subunit messenger RNAs in embryonic chick neurons in culture. J Biol Chem. 1991;266:6011-6014.
104. A receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence. J Pharmacol Exp Ther. 2004;310:1234-1245.
105. A receptor δ subunit-deficient mice: recruitment of γ2 subunits. Neuroscience. 2002; 109:733-743.
106. A receptors. J Neurosci. 2006;26:1749-1758.
107. A blockade of prefrontal cortical neurons engaged by working memory. J Neurosci. 2000;20:485-494.
108. Traub RD, Whittington MA, Colling SB, Buzsaki G, Jefferys JG. Analysis of γ rhythms in the rat hippocampus in vitro and in vivo. J Physiol. 1996;493:471-484.
109. Nixon SJ, Tivis R, Parsons OA. Behavioral dysfunction and cognitive efficiency in male and female alcoholics. Alcohol Clin Exp Res. 1995;19:577-581.
110. Parsons OA, Nixon SJ. Cognitive functioning in sober social drinkers: a review of the research since 1986. J Stud Alcohol. 1998;59:180-190.
111. Harris RA, Valenzuela CF, Brozowski S, Chuang L, Hadingham K, Whiting PJ. Adaptation of γ-aminobutyric acid type A receptors to alcohol exposure: studies with stably transfected cells. J Pharmacol Exp Ther. 1998;284:180-188.
112. A receptor assemblies containing α1-subunit in the rat cerebellum and cerebral cortex as determined by immunoprecipitation: lack of modulation by chronic ethanol administration. Brain Res Mol Brain Res. 1999;67:194-199.
113. A receptor assemblies derived from α2-, α3-, β2- and γ2-subunits in the rat cerebral cortex. Brain Res. 2005;1031:134-137.
114. Roca DJ, Rozenberg I, Farrant M, Farb DH. Chronic agonist exposure induces down-regulation and allosteric uncoupling of the γ-aminobutyric acid/benzodiazepine receptor complex. Mol Pharmacol. 1990;37:37-43.
115. A receptors. Int Rev Neurobiol. 1996;39:53-76.
116. A receptor trafficking, channel activity, and functional plasticity of inhibitory synapses. Pharmacol Ther. 2004;102:195-221.
117. A receptors in cerebral cortex. J Neurochem. 2003;86:700-708.
118. A receptor α6 subunit in hippocampal pyramidal neurons produces extrasynaptic receptors and an increased tonic inhibition. Neuropharmacology. 2002;43:530-549.
119. A receptor subtypes requires the γ2 subunit and gephyrin. Nat Neurosci. 1998;1:563-571.
120. A receptors at inhibitory synapses. Nat Neurosci. 2005;8:889-897.
121. Hemmingsen R, Braestrup C, Nielsen M, Barry DI. The benzodiazepine/GABA receptor complex during severe ethanol intoxication and withdrawal in the rat. Acta Psychiatr Scand. 1982;65:120-126.
122. Liljequist S, Tabakoff B. Binding characteristics of 3H-flunitrazepam and CL-218,872 in cerebellum and cortex of C57B1 mice made tolerant to and dependent on phenobarbital or ethanol. Alcohol. 1985;2:215-220.
123. Ulrichsen J, Clemmesen L, Barry D, Hemmingsen R. The GABA/benzodiazepine receptor chloride channel complex during repeated episodes of physical ethanol dependence in the rat. Psychopharmacology (Berl). 1988;96:227-231.
124. Devaud LL, Morrow AL, Criswell HE, Breese GR, Duncan GE. Regional differences in the effects of chronic ethanol administration on [3H]zolpidem binding in rat brain. Alcohol Clin Exp Res. 1995;19:910-914.
125. Mhatre M, Ticku MK. Chronic ethanol treatment selectively increases the binding of inverse agonists for benzodiazepine binding sites in cultured spinal cord neurons. J Pharmacol Exp Ther. 1989;251:164-168.
126. Abi-Dargham A, Gandelman M, Zoghbi SS, Laruelle M, Baldwin RM, Randall P, Zea-Ponce Y, Charney DS, Hoffer PB, Innis RB. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123- iomazenil. J Nucl Med. 1995;36:167-175.
127. A receptor in human alcoholic brain. Brain Res. 1997;751:102-112.
128. A receptor isoform genes in the cerebral cortex of cirrhotic and alcoholic cases assessed by S1 nuclease protection assays. Neurochem Int. 1998;32:375-385.
129. A receptor α1, α4, and β3 subunit mRNA and protein expression in the frontal cortex of human alcoholics. Alcohol Clin Exp Res. 1998;22:815-822.
130. Tran VT, Snyder SH, Major LF, Hawley RJ. GABA receptors are increased in brains of alcoholics. Ann Neurol. 1981;9:289-292.
131. A receptors in damaged cerebral cortex areas in human chronic alcoholics. Alcohol Alcohol Suppl. 1994;2:187-191.
132. Dodd PR, Thomas GJ, Harper CG, Kril JJ. Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver. J Neurochem. 1992;59:1506-1515.
133. A receptor in brain from human cirrhotic and non-cirrhotic alcoholics. Eur J Pharmacol. 1997;326:265-272.
134. Freund G, Ballinger WE. Loss of synaptic receptors can precede morphologic changes induced by alcoholism. Alcohol Alcohol Suppl. 1991;1:385-391.
135. Freund G, Ballinger WE Jr. Decrease of benzodiazepine receptors in frontal cortex of alcoholics. Alcohol. 1988;5:275-282.
136. Freund G, Ballinger WE Jr. Loss of muscarinic and benzodiazepine neuroreceptors from hippocampus of alcohol abusers. Alcohol. 1989;6:23-31.
137. Litton JE, Neiman J, Pauli S, Farde L, Hindmarsh T, Halldin C, Sedvall G. PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psychiatry Res. 1993;50:1-13.
138. Gilman S, Koeppe RA, Adams K, Johnson-Greene D, Junck L, Kluin KJ, Brunberg J, Martorello S, Lohman M. Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics. Ann Neurol. 1996;40:163-171.
139. Lingford-Hughes AR, Acton PD, Gacinovic S, Boddington SJ, Costa DC, Pilowsky LS, Ell PJ, Marshall EJ, Kerwin RW. Levels of γ-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: preliminary findings from an 123I-iomazenil single photon emission tomography study. Alcohol Clin Exp Res. 2000;24:1449-1455.
140. Lingford-Hughes AR, Acton PD, Gacinovic S, Suckling J, Busatto GF, Boddington SJ, Bullmore E, Woodruff PW, Costa DC, Pilowsky LS, Ell PJ, Marshall EJ, Kerwin RW. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br J Psychiatry. 1998;173:116-122.
141. Abi-Dargham A, Krystal JH, Anjilvel S, Scanley BE, Zoghbi S, Baldwin RM, Rajeevan N, Ellis S, Petrakis IL, Seibyl JP, Charney DS, Laruelle M, Innis RB. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil. Am J Psychiatry. 1998;155:1550-1555.
142. Staley JK, Gottschalk PC, Petrakis IL, Gueorguieva R, O'Malley S, Baldwin R, Jatlow P, Verhoeff NP, Perry E, Weinzimmer D, Frohlich E, Ruff E, van Dyke CH, Seibyl JP, Innis RB, Krystal JH. Cortical γ-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to clinical features of alcohol dependence and cigarette smoking. Arch Gen Psychiatry. 2005;62:877-888.
143. Mason GF, Petrakis IL, de Graaf RA, Gueorguieva R, Guidone E, Coric V, Epperson CN, Rothman DL, Krystal JH. Cortical γ-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry. 2006;59:85-93.
144. Hoffman PL, Tabakoff B. Alcohol dependence: a commentary on mechanisms. Alcohol Alcohol. 1996;31:333-340.
145. Tsai GE, Ragan P, Chang R, Chen S, Linnoila VM, Coyle JT. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry. 1998;155:726-732.
146. Goddard AW, Mason GF, Rothman DL, Behar KL, Krystal JH. Reduced cortical GABA neuronal response to benzodiazepine administration in panic disorder. Am J Psychiatry. 2004;161:2186-2193.
147. Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OA, Shulman GI, Navarro V, Petrakis IL, Charney DS, Krystal JH. Preliminary evidence of reduced cortical GABA levels in localized 1H NMR spectra of alcohol dependent and hepatic encephalopathy patients. Am J Psychiatry. 1999;156:952-954.
148. Schuckit MA, Smith TL. An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry. 1996;53:202-210.
149. Schuckit MA, Tsuang JW, Anthenelli RM, Tipp JE, Nurnberger JI Jr. Alcohol challenges in young men from alcoholic pedigrees and control families: a report from the COGA project. J Stud Alcohol. 1996;57:368-377.
150. Heath AC, Madden PA, Bucholz KK, Dinwiddie SH, Slutske WS, Bierut LJ, Rohrbaugh JW, Statham DJ, Dunne MP, Whitfield JB, Martin NG. Genetic differences in alcohol sensitivity and the inheritance of alcoholism risk. Psychol Med. 1999;29:1069-1081.
151. Newlin DB, Thomson JB. Alcohol challenge with sons of alcoholics: a critical review and analysis. Psychol Bull. 1990;108:383-402.
152. Pollock VE. Meta-analysis of subjective sensitivity to alcohol in sons of alcoholics. Am J Psychiatry. 1992;149:1534-1538.
153. Cowley DS, Roy-Byrne PP, Radant A, Hommer DW, Greenblatt DJ, Vitaliano PP, Godon C. Eye movement effects of diazepam in sons of alcoholic fathers and male control subjects. Alcohol Clin Exp Res. 1994;18:324-332.
154. Cowley DS, Roy-Byrne PP, Godon C, Greenblatt DJ, Ries R, Walker RD, Samson HH, Hommer DW. Response to diazepam in sons of alcoholics. Alcohol Clin Exp Res. 1992;16:1057-1063.
155. Sarid-Segal O, Knapp CM, Ciraulo AM, Greenblatt DJ, Shader RI, Ciraulo DA. Decreased EEG sensitivity to alprazolam in subjects with a parental history of alcoholism. J Clin Pharmacol. 2000;40:84-90.
156. Ciraulo DA, Sarid-Segal O, Knapp C, Ciraulo AM, Greenblatt DJ, Shader RI. Liability to alprazolam abuse in daughters of alcoholics. Am J Psychiatry. 1996; 153:956-958.
157. McCaul ME, Turkkan JS, Svikis DS, Bigelow GE. Alcohol and secobarbital effects as a function of familial alcoholism: extended intoxication and increased withdrawal effects. Alcohol Clin Exp Res. 1991;15:94-101.
158. McCaul ME, Turkkan JS, Svikis DS, Bigelow GE. Alcohol and secobarbital effects as a function of familial alcoholism: acute psychophysiological effects. Alcohol Clin Exp Res. 1990;14:704-712.
159. Volkow ND, Wang GJ, Begleiter H, Hitzemann R, Pappas N, Burr G, Pascani K, Wong C, Fowler JS, Wolf AP. Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. Alcohol Clin Exp Res. 1995;19:510-516.
160. Schuckit MA, Duthie LA, Mahler HI, Irwin M, Monteiro MG. Subjective feelings and changes in body sway following diazepam in sons of alcoholics and control subjects. J Stud Alcohol. 1991;52:601-608.
161. A receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet. 2004;74:705-714.
162. Covault J, Gelernter J, Hesselbrock V, Nellissery M, Kranzler HR. Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet. 2004;129:104-109.
163. Lappalainen J, Krupitsky E, Remizov M, Pchelina S, Taraskina A, Zvartau E, Somberg LK, Covault J, Kranzler HR, Krystal JH, Gelernter J. Association between alcoholism and GABRA2 in a Russian population. Alcohol Clin Exp Res. 2005;29:493-498.
164. A receptors expressed in Xenopus oocytes. Br J Pharmacol. 1999;127:377-382.
165. A receptor-mediated inhibition. J Physiol. 2005;562:37-46.
166. Cruz DA, Eggan SM, Lewis DA. Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J Comp Neurol. 2003;465:385-400.
167. A receptor subunits within rat extended amygdala: implications for benzodiazepine action. Brain Res. 2003;964:91-99.
168. Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 2000;290:131-134.
169. A receptor gene locus. Proc Natl Acad Sci U S A. 2002;99:3729-3733.
170. Enoch M-A, Schwartz L, Albaugh B, Virkkunen M, Goldman D. Anxious temperament mediates linkage of GABRA2 haplotypes with alcoholism [abstract]. Biol Psychiatry. 2005;57:67S.
171. Krystal JH, Petrakis IL, Trevisan L, D'Souza DC. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann N Y Acad Sci. 2003;1003:176-184.
172. Radel M, Vallejo RL, Iwata N, Aragon R, Long JC, Virkkunen M, Goldman D. Haplotype-based localization of an alcohol dependence gene to the 5q34 γ-aminobutyric acid type A gene cluster. Arch Gen Psychiatry. 2005;62:47-55.
173. Aγ2 gene cluster and alcohol dependence in a Scottish population. Mol Psychiatry. 1999;4:539-544.
174. A α6, β2, and γ2 gene cluster and alcohol dependence. Alcohol Clin Exp Res. 1999;23:427-431.
175. Schuckit MA, Mazzanti C, Smith TL, Ahmed U, Radel M, Iwata N, Goldman D. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA α6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol Psychiatry. 1999;45:647-651.
176. A receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population. Mol Psychiatry. 2000;5:301-307.
177. A receptor α6 subunit gene in alcoholics and healthy volunteers. Mol Psychiatry. 2000;5:316-319.
178. A α6 Pro385Ser substitution and benzodiazepine sensitivity. Am J Psychiatry. 1999;156:1447-1449.
179. A receptor α6 subunit null allele mice and in inbred C57BL/6J and strain 129/SvJ mice. Alcohol Clin Exp Res. 1998;22:259-265.
180. A receptor γ 2 subunit gene and lack of allelic association with alcoholism among four aboriginal groups and Han Chinese in Taiwan. Brain Res Mol Brain Res. 1998;56:284-286.
181. A receptors. Biochem Biophys Res Commun. 1997;238:683-685.
182. A receptor γ2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines. BMC Neurosci. 2005;6:30.
183. A receptor α1 subunit-containing receptors alters responses to ethanol and other anesthetics. J Pharmacol Exp Ther. 2003;305:600-607.
184. A receptor α1 subunit knockout mice. J Pharmacol Exp Ther. 2002;302:1037-1045.
185. A receptor α1 and α3 subunits genes and alcoholism. Alcohol Clin Exp Res. 1997;21:430-433.
186. Dick DM, Edenberg HJ, Xuei X, Goate A, Kuperman S, Schuckit M, Crowe R, Smith TL, Porjesz B, Begleiter H, Foroud T. Association of GABRG3 with alcohol dependence. Alcohol Clin Exp Res. 2004;28:4-9.
187. Dani JA, Harris RA. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci. 2005;8:1465-1470.
188. Batel P, Pessione F, Maitre C, Rueff B. Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction. 1995;90:977-980.
189. Daeppen JB, Smith TL, Danko GP, Gordon L, Landi NA, Nurnberger JI Jr, Bucholz KK, Raimo E, Schuckit MA; Collaborative Study Group on the Genetics of Alcoholism. Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. Alcohol Alcohol. 2000;35:171-175.
190. Gulliver SB, Kalman D, Rohsenow DJ, Colby SM, Eaton CA, Monti PM. Smoking and drinking among alcoholics in treatment: cross-sectional and longitudinal relationships. J Stud Alcohol. 2000;61:157-163.
191. Toneatto A, Sobell LC, Sobell MB, Kozlowski LT. Effect of cigarette smoking on alcohol treatment outcome. J Subst Abuse. 1995;7:245-252.
192. Aubin HJ, Laureaux C, Tilikete S, Barrucand D. Changes in cigarette smoking and coffee drinking after alcohol detoxification in alcoholics. Addiction. 1999;94:411-416.
193. Carmelli D, Swan GE, Robinette D. The relationship between quitting smoking and changes in drinking in World War II veteran twins. J Subst Abuse. 1993;5:103-116.
194. Palfai TP, Monti PM, Ostafin B, Hutchison K. Effects of nicotine deprivation on alcohol-related information processing and drinking behavior. J Abnorm Psychol. 2000;109:96-105.
195. Hulo S, Muller D. Tetrodotoxin-sensitive enhancement of inhibition in CA1 pyramidal neurones by nicotine. Neuroreport. 2001;12:1351-1354.
196. Perez de la Mora M, Mendez-Franco J, Salceda R, Aguirre JA, Fuxe K. Neurochemical effects of nicotine on glutamate and GABA mechanisms in the rat brain. Acta Physiol Scand. 1991;141:241-250.
197. Zhu PJ, Chiappinelli VA. Nicotine modulates evoked GABAergic transmission in the brain. J Neurophysiol. 1999;82:3041-3045.
198. Berta L, Frairia R, Fortunati N, Fazzari A, Gaidano G. Smoking effects on the hormonal balance of fertile women. Horm Res. 1992;37:45-48.
199. Bodis J, Hanf V, Torok A, Tinneberg HR, Borsay P, Szabo I. Influence of nicotine on progesterone and estradiol production of cultured human granulosa cells. Early Pregnancy. 1997;3:34-37.
200. Friedman AJ, Ravnikar VA, Barbieri RL. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril. 1987;47:398-401.
201. Key TJ, Pike MC, Baron JA, Moore JW, Wang DY, Thomas BS, Bulbrook RD. Cigarette smoking and steroid hormones in women. J Steroid Biochem Mol Biol. 1991;39:529-534.
202. Baron JA, Comi RJ, Cryns V, Brinck-Johnsen T, Mercer NG. The effect of cigarette smoking on adrenal cortical hormones. J Pharmacol Exp Ther. 1995; 272:151-155.
203. Parfenova H, Daley ML, Carratu P, Leffler CW. Heme oxygenase inhibition reduces neuronal activation evoked by bicuculline in newborn pigs. Brain Res. 2004;1014:87-96.
204. Cain M, Weber RW, Guzman F, Cook JM, Barker SA, Rice KC, Crawley JN, Paul SM, Skolnick P. β-Carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors. J Med Chem. 1982;25:1081-1091.
205. Tsuchiya H, Ohtani S, Yamada K, Tajima K, Sato M. Formation of tetrahydro-β-carbolines in human saliva. Biochem Pharmacol. 1995;50:2109-2112.
206. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I. Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. J Addict Dis. 1998;17:23-34.
207. Soto-Otero R, Mendez-Alvarez E, Riguera-Vega R, Quinoa-Cabana E, Sanchez-Sellero I, Lopez-Rivadulla Lamas M. Studies on the interaction between 1,2,3,4-tetrahydro-β-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease. Brain Res. 1998;802:155-162.
208. Rommelspacher H, Dufeu P, Schmidt LG. Harman and norharman in alcoholism: correlations with psychopathology and long-term changes. Alcohol Clin Exp Res. 1996;20:3-8.
209. Spijkerman R, van den Eijnden R, van de Mheen D, Bongers I, Fekkes D. The impact of smoking and drinking on plasma levels of norharman. Eur Neuropsychopharmacol. 2002;12:61-71.
210. O'Dell LE, Purdy RH, Covey DF, Richardson HN, Roberto M, Koob GF. Epipregnanolone and a novel synthetic neuroactive steroid reduce alcohol self-administration in rats. Pharmacol Biochem Behav. 2005;81:543-550.
211. Koob GF. A role for GABA mechanisms in the motivational effects of alcohol. Biochem Pharmacol. 2004;68:1515-1525.
212. June HL, Hughes RW, Spurlock HL, Lewis MJ. Ethanol self-administration in freely feeding and drinking rats: effects of Ro15-4513 alone, and in combination with Ro15-1788 (flumazenil). Psychopharmacology (Berl). 1994;115:332-339.
213. Rassnick S, D'Amico E, Riley E, Koob GF. GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol. Alcohol Clin Exp Res. 1993;17:124-130.
214. Samson HH, Haraguchi M, Tolliver GA, Sadeghi KG. Antagonism of ethanol-reinforced behavior by the benzodiazepine inverse agonists Ro15-4513 and FG 7142: relation to sucrose reinforcement. Pharmacol Biochem Behav. 1989;33:601-608.
215. D'Souza DC, Gil R, Zuzarte E, MacDougall L, Donahue L, Ebersole JS, Boutros NN, Cooper T, Seibyl J, Krystal JH. γ-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation. Biol Psychiatry. 2006;59:128-137.
216. Dorow R, Horowski R, Paschelke G, Amin M. Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors. Lancet. 1983;2:98-99.
217. Corda MG, Giorgi O, Longoni B, Biggio G. Ro 15-4513, a partial inverse agonist for benzodiazepine recognition sites, has proconflict and proconvulsant effects in the rat. Eur J Pharmacol. 1989;159:233-239.
218. A receptors. Adv Biochem Psychopharmacol. 1995;48:57-74.
219. A receptor function. Trends Pharmacol Sci. 1995;16:295-303.
220. Reoux JP, Saxon AJ, Malte CA, Baer JS, Sloan KL. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. Alcohol Clin Exp Res. 2001;25:1324-1329.
221. Mueller TI, Stout RL, Rudden S, Brown RA, Gordon A, Solomon DA, Recupero PR. A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res. 1997;21:86-92.
222. Stuppaeck CH, Deisenhammer EA, Kurz M, Whitworth AB, Hinterhuber H. The irreversible γ-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome [letter]. Alcohol Alcohol. 1996;31:109-111.
223. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med. 2002;17:349-355.
224. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003;361:1677-1685.
225. 4 subunit gene induced by withdrawal of, but not by longterm treatment with, benzodiazepine full or partial agonists. Brain Res Mol Brain Res. 2001;92:138-148.
226. Nusser Z, Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J Neurophysiol. 2002;87:2624-2628.
227. Aergic inhibition in a mouse model. Eur J Neurosci. 2004; 20:2168-2178.
228. Krupitsky EM, Rudenko AA, Burakov AM, Slavina TY, Grinenko AA, Pittman B, Gueorguieva R, Petrakis IL, Zuartau EE, Krystal JH. Antiglutamatergic strategies for ethanol detoxification: comparison to placebo and diazepam. Alc Clin Exp Res. 2003;27:149A.
229. A receptors expressed in Xenopus oocytes to modulation by topiramate. Epilepsia. 2000;41(suppl 1):S25-S29.
230. Petroff OA, Hyder F, Rothman DL, Mattson RH. Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia. 2001;42:543-548.
231. Petroff OA, Hyder F, Mattson RH, Rothman DL. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology. 1999;52:473-478.